SEC Comment Letter for ORAGENICS INC (OGEN) (CIK 0001174940) (OGEN) — May 23, 2018

ORAGENICS INC (OGEN) (CIK 0001174940)
Date: May 23, 2018 · CIK: 0001174940 · Accession: 0000000000-18-016008

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-224950

Date

May 23, 2018

Author

Alan Joslyn

Form

UPLOAD

Company

ORAGENICS INC (OGEN) (CIK 0001174940)

Letter

May 23, 2018 Alan Joslyn Chief Executive Officer Oragenics, Inc. 4902 Eisenhower Boulevard, Suite 125 Tampa, FL 33634 Re:Oragenics, Inc. Registration Statement on Form S-1 Filed May 15, 2018 File No. 333-224950 Dear Mr. Joslyn: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Dorrie Yale at 202-551-8776 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Mark A. Catchur

Show Raw Text

May 23, 2018
Alan Joslyn
Chief Executive Officer
Oragenics, Inc.
4902 Eisenhower Boulevard, Suite 125
Tampa, FL 33634
Re:Oragenics, Inc.
Registration Statement on Form S-1
Filed May 15, 2018
File No. 333-224950
Dear Mr. Joslyn:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Dorrie Yale at 202-551-8776 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc:       Mark A. Catchur

SecProbe.io